KIT DE PRUEBA PARA DETERMINACIÓN DE HEMOGLOBINA GLICOSILADA
Mexico·Clase I·III. Agentes de
diagnóstico·QUIMIBIOL, S.A. DE C.V.·Registered April 19, 2024- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- MEXLAB BIO-HB1AC KIT DE PRUEBA PARA GLICOHEMOGLOBINA (MÉTODO DE INMUNOENSAYO PARA NEFELOMETRÍA)
- Trade Name (English)
- MEXLAB BIO-HB1AC KIT DE PRUEBA PARA GLICOHEMOGLOBINA (MÉTODO DE INMUNOENSAYO PARA NEFELOMETRÍA)
- Analysis ID
- 1136R2024 SSA
- Registration Date
- April 19, 2024
- Name (Spanish)
- QUIMIBIOL, S.A. DE C.V.
- Name (English)
- QUIMIBIOL, S.A. DE C.V.
Access comprehensive regulatory information for KIT DE PRUEBA PARA DETERMINACIÓN DE HEMOGLOBINA GLICOSILADA (KIT DE PRUEBA PARA DETERMINACIÓN DE HEMOGLOBINA GLICOSILADA) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1136R2024 SSA and manufactured by QUIMIBIOL, S.A. DE C.V.. The device was registered on April 19, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.